HCV - Third Wave, Chiron, Bayer dismiss HCV patent suit

Third Wave, Chiron, Bayer dismiss HCV patent suit
Reuters UK - CHICAGO (Reuters) - Third Wave Technologies Inc. on Thursday said it reached an agreement with Chiron Corp. and Bayer Corp. to dismiss its lawsuit against Chiron and Bayer over patents related to hepatitis C virus, or HCV. Terms of the agreement were

Viral hepatitis C management involves some tough decisions
Managed Healthcare Executive - From a care delivery standpoint, identifying and treating patients with the hepatitis C virus (HCV) is a complicated and difficult process. It's the most prevalent liver disease in the world, with as many as 300 million people afflicted with the

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

Drug cocktail offers hope for HCV sufferers
Daily Yomiuri On-Line - I am infected with the hepatitis C virus. But the virus has been eliminated from my blood thanks to a new treatment that uses a cocktail of peginterferon and ribavirin. This new combination may be a cure for many people with HCV. I have been taking